Literature DB >> 35702401

Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

Joshua D Brown1,2, Amie J Goodin1,2.   

Abstract

Entities:  

Keywords:  COVID-19; Cannabidiol; Cannabinoids and COVID-19; Cannabis and COVID-19; Drug repurposing; Medical cannabis; Medical marijuana; SARS-CoV-2; Tetrahydrocannabinol

Year:  2022        PMID: 35702401      PMCID: PMC9149510          DOI: 10.1159/000522472

Source DB:  PubMed          Journal:  Med Cannabis Cannabinoids        ISSN: 2504-3889


× No keyword cloud information.
  21 in total

Review 1.  Artificial Intelligence for Clinical Trial Design.

Authors:  Stefan Harrer; Pratik Shah; Bhavna Antony; Jianying Hu
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

2.  Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions.

Authors:  Joshua D Brown; Kevin J Rivera Rivera; Leilanie Y Crespo Hernandez; Matthew R Doenges; India Auchey; Thanh Pham; Amie J Goodin
Journal:  J Clin Pharmacol       Date:  2021-08       Impact factor: 3.126

3.  The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Authors:  Jack M Lawrence; Gideon Meyerowitz-Katz; James A J Heathers; Nicholas J L Brown; Kyle A Sheldrick
Journal:  Nat Med       Date:  2021-11       Impact factor: 53.440

4.  Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.

Authors:  Eli S Rosenberg; Elizabeth M Dufort; Tomoko Udo; Larissa A Wilberschied; Jessica Kumar; James Tesoriero; Patti Weinberg; James Kirkwood; Alison Muse; Jack DeHovitz; Debra S Blog; Brad Hutton; David R Holtgrave; Howard A Zucker
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

Review 5.  A review on drug repurposing applicable to COVID-19.

Authors:  Serena Dotolo; Anna Marabotti; Angelo Facchiano; Roberto Tagliaferri
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

6.  Cannabinoids and Viral Infections.

Authors:  Carol Shoshkes Reiss
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-01

7.  Combating COVID-19: The role of drug repurposing and medicinal plants.

Authors:  Shah A Khan; K Al-Balushi
Journal:  J Infect Public Health       Date:  2020-10-27       Impact factor: 3.718

8.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.

Authors:  Richard B van Breemen; Ruth N Muchiri; Timothy A Bates; Jules B Weinstein; Hans C Leier; Scotland Farley; Fikadu G Tafesse
Journal:  J Nat Prod       Date:  2022-01-10       Impact factor: 4.050

Review 9.  Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions.

Authors:  Joshua D Brown
Journal:  J Clin Med       Date:  2020-03-27       Impact factor: 4.241

10.  The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.

Authors:  Virginia D Schmith; Jie Jessie Zhou; Lauren R L Lohmer
Journal:  Clin Pharmacol Ther       Date:  2020-06-07       Impact factor: 6.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.